To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
320 Current news of Merckrss
|You can refine your search further. Select from the filter options on the left to narrow down your results.|
With the addition of around 100 new employees as well as state-of-the-art production and R&D facilities in Korea, Merck will expand both its regional and global capabilities
Merck announced the closing of the transaction to acquire M Chemicals Inc., the company recently incorporated by Mecaro Co. Ltd. to operate its chemical business. Combining these two businesses is expected to complement a key segment of Merck’s Semiconductor Solutions portfolio, while ...
Merck continued to grow despite a challenging external operating environment
Group sales increased by 16.8% to €5,806 million. The “Big 3” – Process Solutions and Life Science Services, new Healthcare products as well as Semiconductor Solutions – were the key drivers of the strong, 7.1% organic increase in sales. Despite higher costs for raw materials, energy and ...
Automation and digitalization of production processes
Merck commissioned its first fully automated unit for the digital color measurement of its pigment products. The unit was commissioned in Gernsheim, Germany, the company’s largest pigments production site. Approximately 560 people work at the site. “We have invested tremendously in recent years ...
Targeted acquisition to drive innovation in Semiconductor Solutions
Merck has signed a definitive agreement to acquire the chemical business of Mecaro Co. Ltd. (Mecaro), a Korea-based and publicly listed manufacturer of heater blocks and chemical precursors for semiconductors. The acquisition is part of the Level Up growth program of Merck’s Electronics business ...
Prizewinner from the Max Planck Institute in Marburg, Germany is working on capturing carbon dioxide and converting it into new chemical building blocks using biocatalysts
Merck announced the winner of the 2022 Future Insight Prize in the category of “Energy”. The €1million prize was awarded at the “Curious2022 – Future Insight” scientific conference in Darmstadt, Germany, to Professor Tobias Erb (43), Director at the Max Planck Institute for Terrestrial ...
The three-year collaboration will focus on the development of new tools for computational chemistry modelling as well as new molecular representations
Merck announced a collaboration with the Mulliken Center for Theoretical Chemistry at the Rheinische Friedrich-Wilhelms-University of Bonn, Germany. The three-year collaboration will focus on the development of new tools for computational chemistry modelling as well as new molecular ...
High margins in all three businesses despite challenging economic headwinds and increasing global uncertainty
Merck achieved strong results in the first quarter of 2022. Net sales increased by 12.2% to € 5,198 million compared with the year-earlier quarter. All three business sectors contributed to this growth. The key drivers were the company’s Big3 businesses – the Process Solutions business of Life ...
The groundbreaking aspect of her work centers on making circular dichroism ion spectroscopy feasible for large biomolecule ions
Merck, a leading science and technology company, today presented Dr. Valérie Gabelica (44), Inserm, and Director of IECB, Pessac, France, with the 2022 Heinrich Emanuel Merck Award for Analytical Science. The award ceremony took place during the analytical conference EuroFAST2022, Nijmegen, the ...
Greater investments in high-growth businesses
Merck delivered record growth in fiscal 2021. In the course of the year, the company had already raised its business forecast three times. Group net sales increased by 12.3% to €19.7 billion compared with the previous year. All three business sectors, first and foremost Life Science, contributed ...
“Over the past decade, M Ventures has established itself globally as a leading partner to the biotech and tech venture ecosystems”
Merck announced the expansion of its strategic, corporate venture capital arm M Ventures. The new investment of €600 million allocated to M Ventures will be deployed over the next five years. This is the third increase in financial commitment announced by Merck since the creation of M Ventures ...